NewsRx

Search our medical news database

Philanthropy

Center for Molecular Biotechnology gets grant for trypanosomiasis research

Published in Vaccine Weekly, June 15th, 2005

Fraunhofer USA's Center for Molecular Biotechnology (CMB), a nonprofit research organization based in Newark, Delaware, has received a $1.2 million grant from the Bill & Melinda Gates Foundation for preclinical studies towards the development of a vaccine against African trypanosomiasis.

The disease, known in cattle as Nagana and in humans as Sleeping Sickness, is spread by the bite of the tsetse fly and is fatal if left untreated. It occurs in 36 countries of sub-Saharan Africa. It is reaching epidemic proportions and is having a devastating impact on local economies there.

CMB will apply its newly developed suite of technologies to engineer,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook